BIOPIX-T launches its portable molecular diagnostic device “PEBBLE” with the COVID19 test for the point of care!
At BIOPIX-T we are pleased to announce that the portable molecular diagnostic platform “PEBBLE” and its compatible diagnostic test for the detection of Coronavirus are now commercially available! The “PEBBLE qcLAMP Platform“, as its full name is, is the first Greek portable molecular diagnostic device based on LAMP technology (Isothermal PCR), which can be used at the Point-of-Care. It is notified to […]read more
BIOPIX-T receives the ISO/IEC 27001:2013 certification and expands its ISO 13485:2016
BIOPIX-T (www.biopix-t.com ) is pleased to announce that its information security management system (ISMS) has been certified as per ISO/IEC 27001:2013 by DQS Hellas. Moreover, BIOPIX-T successfully audited for the extension of the scope of its ISO 13485:2016, also by DQS Hellas, to additionally include the “Technical Support” and also cover its new manufacturing premises. Our new certification as per ISO/IEC 27001:2013 confirms […]read more
Eleven invests in the Greek biotech company BIOPIX-T
After the initial investment from Metavallon.vc, we are exited to be also included in the portfolio of Eleven Ventures, further broadening the institutional support we receive and our geographical footprint! On the investment in BIOPIX-T Valeri Petrov, Partner at Eleven Ventures explains: “BIOPIX-T is our first investment in Greece and the company fits perfectly in one of our […]read more
BIOPIX-T CERTIFIED AS PER ISO 13485:2016
BIOPIX-T (www.biopix-t.com ) is pleased to announce that its quality management system (QMS) has been successfully certified as per ISO 13485:2016 requirements by DQS Hellas, with scope “Design and Development, Production, Storage and Distribution of nucleic acid amplification kits (COV19 qc LAMP kit and Flu A qc LAMP kit) and instruments (Pebble qc LAMP platform)”. Our ISO 13485:2016 certification serves our mission to offer safe portable In-Vitro diagnostic medical devices […]read more